| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |